{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T11:19:00Z","timestamp":1788347940250,"version":"build-2803163510"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"9-10","license":[{"start":{"date-parts":[[2020,4,9]],"date-time":"2020-04-09T00:00:00Z","timestamp":1586390400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,4,9]],"date-time":"2020-04-09T00:00:00Z","timestamp":1586390400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Wien Med Wochenschr"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s10354-020-00748-z","type":"journal-article","created":{"date-parts":[[2020,4,9]],"date-time":"2020-04-09T15:03:46Z","timestamp":1586444626000},"page":"218-223","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["No evidence of occult HBV infection in population born after mass vaccination"],"prefix":"10.1007","volume":"170","author":[{"given":"Mohammad Reza","family":"Aghasadeghi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arezoo","family":"Aghakhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Setareh","family":"Mamishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farahnaz","family":"Bidari-Zerehpoosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad-Taghi","family":"Haghi Ashtiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahram","family":"Sabeti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Banifazl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afsaneh","family":"Karami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anahita","family":"Bavand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amitis","family":"Ramezani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,9]]},"reference":[{"issue":"12","key":"748_CR1","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1056\/NEJMra1001683","volume":"365","author":"HB El-Seraq","year":"2011","unstructured":"El-Seraq\u00a0HB. Hepatocellular carcinoma. N\u00a0Engl J Med. 2011;365(12):1118\u201327. https:\/\/doi.org\/10.1056\/NEJMra1001683.","journal-title":"N Engl J Med"},{"issue":"8","key":"748_CR2","doi-asserted-by":"publisher","first-page":"e753","DOI":"10.1371\/journal.pone.0000753","volume":"2","author":"MA van der Sande","year":"2007","unstructured":"van der Sande\u00a0MA, Waight\u00a0PA, Mendy\u00a0M, Zaman\u00a0S, Kaye\u00a0S, Sam\u00a0O et al. Long-term protection against HBV chronic carriage of Gambian adolescents vaccinated in infancy and immune response in HBV booster trial in adolescence. PLoS One. 2007;2(8):e753. https:\/\/doi.org\/10.1371\/journal.pone.0000753.","journal-title":"PLoS One"},{"key":"748_CR3","doi-asserted-by":"publisher","first-page":"463","DOI":"10.3851\/IMP1555","volume":"15","author":"MH Chang","year":"2010","unstructured":"Chang\u00a0MH. Breakthrough HBV infection in vaccinated children in Taiwan. Surveillance for HBV mutants. Antivir Ther. 2010;15:463\u20139. https:\/\/doi.org\/10.3851\/IMP1555.","journal-title":"Antivir Ther"},{"key":"748_CR4","doi-asserted-by":"publisher","first-page":"333","DOI":"10.7326\/0003-4819-142-5-200503010-00008","volume":"142","author":"BJ McMahon","year":"2005","unstructured":"McMahon\u00a0BJ, Bruden\u00a0DL, Petersen\u00a0KM, Bulkow\u00a0LR, Parkinson\u00a0AJ, et al. Antibody levels and protection after hepatitis B vaccination: results of a\u00a015-year follow up. Ann Intern Med. 2005;142:333\u201341. https:\/\/doi.org\/10.7326\/0003-4819-142-5-200503010-00008.","journal-title":"Ann Intern Med"},{"key":"748_CR5","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1086\/514610","volume":"27","author":"SL Ngui","year":"1998","unstructured":"Ngui\u00a0SL, Andrews\u00a0NJ, Underhill\u00a0GS, Heptonstall\u00a0J, Teo\u00a0CG. Failed postnatal immunoprophylaxis for hepatitis B: characteristics of maternal hepatitis B virus as risk factors. Clin Infect Dis. 1998;27:100\u20136.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"748_CR6","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.jhep.2019.03.034","volume":"71","author":"G Raimondo","year":"2019","unstructured":"Raimondo\u00a0G, Locarnini\u00a0S, Pollicino\u00a0T, Levrero\u00a0M, Zoulim\u00a0F, et\u00a0al. Update of the statements on biology and clinical impact of occult hepatitis B virus infection. J\u00a0Hepatol. 2019;71(2):397\u2013408.","journal-title":"J Hepatol"},{"issue":"11","key":"748_CR7","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1177\/0956462415602419","volume":"27","author":"A Aghakhani","year":"2016","unstructured":"Aghakhani\u00a0A, Mohraz\u00a0M, Aghasadeghi\u00a0MR, Banifazl\u00a0M, Vahabpour\u00a0R, et al. Occult hepatitis B virus infection and S gene escape mutants in HIV-infected patients after hepatitis B virus vaccination. Int J STD Aids. 2016;27(11):967\u201372. https:\/\/doi.org\/10.1177\/0956462415602419.","journal-title":"Int J STD Aids"},{"issue":"3","key":"748_CR8","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1111\/j.1744-9987.2009.00798.x","volume":"14","author":"A Aghakhani","year":"2010","unstructured":"Aghakhani\u00a0A, Banifazl\u00a0M, Kalantar\u00a0E, Eslamifar\u00a0A, Ahmadi\u00a0F, Razeghi\u00a0E, et\u00a0al. Occult hepatitis B virus infection in hemodialysis patients with isolated hepatitis B core antibody. A\u00a0multicenter study. Ther Apher Dial. 2010;14(3):349\u201353. https:\/\/doi.org\/10.1111\/j.1744-9987.2009.00798.x.","journal-title":"Ther Apher Dial"},{"issue":"4","key":"748_CR9","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1159\/000160217","volume":"51","author":"K Azadmanesh","year":"2008","unstructured":"Azadmanesh\u00a0K, Mohraz\u00a0M, Aghakhani\u00a0A, Edalat\u00a0R, Jam\u00a0S, Eslamifar\u00a0A et al. Occult hepatitis B virus infection in HIV-infected patients with isolated hepatitis B core antibody. Intervirology. 2008;51(4):270\u20134. https:\/\/doi.org\/10.1159\/000160217.","journal-title":"Intervirology"},{"key":"748_CR10","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1002\/hep.29022","volume":"65","author":"WK Seto","year":"2017","unstructured":"Seto\u00a0WK, Chan\u00a0TS, Hwang\u00a0YY, Wong\u00a0DK, Fung\u00a0J, Liu\u00a0KS, et\u00a0al. Hepatitis B reactivation in occult viral carriers undergoing hematopoietic stem cell transplantation: a\u00a0prospective study. Hepatology. 2017;65:1451\u201361.","journal-title":"Hepatology"},{"key":"748_CR11","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1002\/hep.27650","volume":"61","author":"HY Hsu","year":"2015","unstructured":"Hsu\u00a0HY, Chang\u00a0MH, Ni\u00a0YH, Chiang\u00a0CL, Wu\u00a0JF, Chen\u00a0HL. Universal infant immunization and occult hepatitis B virus infection in children and adolescents: a\u00a0population-based study. Hepatology. 2015;61:1183\u201391.","journal-title":"Hepatology"},{"issue":"1","key":"748_CR12","doi-asserted-by":"publisher","first-page":"e22674","DOI":"10.5812\/numonthly.22674","volume":"7","author":"A Ramezani","year":"2014","unstructured":"Ramezani\u00a0A, Aghasadeghi\u00a0MR, Ahmadi\u00a0F, Razeghi\u00a0E, Eslamifar\u00a0A, Banifazl\u00a0M, et al. Isolated anti-hbc and occult HBV infection in dialysis patients. Nephrourol Mon. 2014;7(1):e22674. https:\/\/doi.org\/10.5812\/numonthly.22674.","journal-title":"Nephrourol Mon"},{"key":"748_CR13","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.1111\/liv.12807","volume":"35","author":"C Saitta","year":"2015","unstructured":"Saitta\u00a0C, Tripodi\u00a0G, Barbera\u00a0A, Bertuccio\u00a0A, Smedile\u00a0A, Ciancio\u00a0A, et\u00a0al. Hepatitis B virus (HBV) DNA integration in patients with occult HBV infection and hepatocellular carcinoma. Liver Int. 2015;35:2311\u20137.","journal-title":"Liver Int"},{"issue":"32","key":"748_CR14","doi-asserted-by":"publisher","first-page":"7264","DOI":"10.3748\/wjg.v22.i32.7264","volume":"22","author":"M Lusida","year":"2016","unstructured":"Lusida\u00a0M, Juniastuti, Yano\u00a0Y. Current hepatitis B virus infection situation in Indonesia and its genetic diversity. World J Gastroenterol. 2016;22(32):7264\u201374. https:\/\/doi.org\/10.3748\/wjg.v22.i32.7264.","journal-title":"World J Gastroenterol"},{"key":"748_CR15","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1007\/s10096-015-2422-x","volume":"34","author":"RA Ponde","year":"2015","unstructured":"Ponde\u00a0RA. Molecular mechanisms underlying HBsAg negativity in occult HBV infection. Eur J Clin Microbiol Infect Dis. 2015;34:1709\u201331.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"748_CR16","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/S1473-3099(02)00345-6","volume":"2","author":"M Torbenson","year":"2002","unstructured":"Torbenson\u00a0M, Thomas\u00a0DL. Occult hepatitis B. Lancet Infect Dis. 2002;2:479\u201386. https:\/\/doi.org\/10.1016\/S1473-3099(02)00345-6.","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"748_CR17","doi-asserted-by":"publisher","first-page":"13595","DOI":"10.3390\/ijms160613595","volume":"16","author":"H Kim","year":"2015","unstructured":"Kim\u00a0H, Kim\u00a0BJ. Association of preS\/S mutations with occult hepatitis B virus (HBV) infection in South Korea. Transmission potential of distinct occult HBV variants. Int J Mol Sci. 2015;16(6):13595\u2013609. https:\/\/doi.org\/10.3390\/ijms160613595.","journal-title":"Int J Mol Sci"},{"key":"748_CR18","doi-asserted-by":"publisher","first-page":"445","DOI":"10.3851\/IMP1556","volume":"15","author":"CG Teo","year":"2010","unstructured":"Teo\u00a0CG, Locarnini\u00a0S. Potential threat of drug-resistant and vaccine-escape HBV mutants to public health. Antivir Ther. 2010;15:445\u20139.","journal-title":"Antivir Ther"},{"issue":"4","key":"748_CR19","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.jhep.2012.05.009","volume":"57","author":"C-H Huang","year":"2012","unstructured":"Huang\u00a0C\u2011H, Yuan\u00a0Q, Chen\u00a0PJ, Zhang\u00a0YL, Chen\u00a0CR, Zheng\u00a0QB, et al. Influence of mutations in hepatitis B virus surface protein on viral antigenicity and phenotype in occult HBV strains from blood donors. J\u00a0Hepatol. 2012;57(4):720\u20139.","journal-title":"J Hepatol"},{"key":"748_CR20","first-page":"11","volume":"67","author":"World Health Organization","year":"1992","unstructured":"World Health Organization. Expanded programme on immunization. Global advisory group. Wkly Epidemiol Rec. 1992;67:11\u20136.","journal-title":"Wkly Epidemiol Rec"},{"issue":"2","key":"748_CR21","doi-asserted-by":"publisher","first-page":"e82","DOI":"10.1016\/j.ijid.2011.10.009","volume":"16","author":"Z Luo","year":"2012","unstructured":"Luo\u00a0Z, Li\u00a0L, Ruan\u00a0B. Impact of the implementation of a\u00a0vaccination strategy on hepatitis B virus infections in China over a\u00a020-year period. Int J Infect Dis. 2012;16(2):e82\u20138. https:\/\/doi.org\/10.1016\/j.ijid.2011.10.009.","journal-title":"Int J Infect Dis"},{"issue":"2","key":"748_CR22","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1046\/j.1365-2893.2003.00487.x","volume":"11","author":"D Lavanchy","year":"2004","unstructured":"Lavanchy\u00a0D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J\u00a0Viral Hepat. 2004;11(2):97\u2013107.","journal-title":"J Viral Hepat"},{"issue":"4","key":"748_CR23","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.cld.2016.06.006","volume":"20","author":"NP Nelson","year":"2016","unstructured":"Nelson\u00a0NP, Easterbrook\u00a0PJ, McMahon\u00a0BJ. Epidemiology of hepatitis B virus infection and impact of vaccination on disease. Clin Liver Dis. 2016;20(4):607\u201328.","journal-title":"Clin Liver Dis"},{"key":"748_CR24","doi-asserted-by":"publisher","first-page":"E3","DOI":"10.1046\/j.1440-1746.2000.02124.x","volume":"15","author":"CJ Chen","year":"2000","unstructured":"Chen\u00a0CJ, Wang\u00a0LY, Yu\u00a0MW. Epidemiology of hepatitis B virus infection in the Asia\u2013Pacific region. J\u00a0Gastroenterol Hepatol. 2000;15:E3\u2013E6.","journal-title":"J Gastroenterol Hepatol"},{"key":"748_CR25","doi-asserted-by":"publisher","first-page":"2791","DOI":"10.1016\/j.vaccine.2004.01.046","volume":"22","author":"AA Basuni","year":"2004","unstructured":"Basuni\u00a0AA, Butterworth\u00a0L, Cooksley\u00a0G, Locarnini\u00a0S, Carman\u00a0WF. Prevalence of HBsAg mutants and impact of hepatitis B infant immunisation in four Pacific Island countries. Vaccine. 2004;22:2791\u20139. https:\/\/doi.org\/10.1016\/j.vaccine.2004.01.046.","journal-title":"Vaccine"},{"key":"748_CR26","doi-asserted-by":"publisher","first-page":"4158","DOI":"10.1016\/j.vaccine.2005.03.017","volume":"23","author":"D Fitzsimons","year":"2005","unstructured":"Fitzsimons\u00a0D, Fran\u00e7ois\u00a0G, Hall\u00a0A, McMahon\u00a0B, Meheus\u00a0A, et al. Long-term efficacy of hepatitis B vaccine, booster policy, and impact of hepatitis B virus mutants. Vaccine. 2005;23:4158\u201366. https:\/\/doi.org\/10.1016\/j.vaccine.2005.03.017.","journal-title":"Vaccine"},{"key":"748_CR27","doi-asserted-by":"publisher","first-page":"2946","DOI":"10.1016\/S0264-410X(99)00178-4","volume":"17","author":"S Viviani","year":"1999","unstructured":"Viviani\u00a0S, Jack\u00a0A, Hall\u00a0AJ, Maine\u00a0N, Mendy\u00a0M, et\u00a0al. Hepatitis B vaccination in infancy in The Gambia: protection against carriage at 9 years of age. Vaccine. 1999;17:2946\u201350. https:\/\/doi.org\/10.1016\/S0264-410X(99)00178-4.","journal-title":"Vaccine"},{"key":"748_CR28","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1186\/1471-2334-13-286","volume":"13","author":"NP Komas","year":"2013","unstructured":"Komas\u00a0NP, Vickos\u00a0U, H\u00fcbschen\u00a0JM, B\u00e9r\u00e9\u00a0A, Manirakiza\u00a0A, et al. Cross-sectional study of hepatitis B virus infection in rural communities, Central African Republic. BMC Infect Dis. 2013;13:286.","journal-title":"BMC Infect Dis"},{"issue":"3","key":"748_CR29","doi-asserted-by":"publisher","first-page":"359","DOI":"10.3346\/jkms.2001.16.3.359","volume":"16","author":"KM Lee","year":"2001","unstructured":"Lee\u00a0KM, Kim\u00a0YS, Ko\u00a0YY, Yoo\u00a0BM, Lee\u00a0KJ, et al. Emergence of vaccine-induced escape mutant of hepatitis B virus with multiple surface gene mutations in a\u00a0Korean child. J\u00a0Korean Med Sci. 2001;16(3):359\u201362. https:\/\/doi.org\/10.3346\/jkms.2001.16.3.359.","journal-title":"J Korean Med Sci"},{"key":"748_CR30","doi-asserted-by":"publisher","first-page":"571875","DOI":"10.1155\/2013\/571875","volume":"2013","author":"YM Lin","year":"2013","unstructured":"Lin\u00a0YM, Jow\u00a0GM, Mu\u00a0SC, Chen\u00a0BF. Naturally occurring hepatitis B virus B\u2011cell and T\u2011cell epitope mutants in hepatitis B vaccinated children. ScientificWorldJournal. 2013;2013:571875. https:\/\/doi.org\/10.1155\/2013\/571875.","journal-title":"ScientificWorldJournal"},{"issue":"4","key":"748_CR31","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.hepres.2006.08.001","volume":"36","author":"A Kabir","year":"2006","unstructured":"Kabir\u00a0A, Alavian\u00a0SM, Ahanchi\u00a0N, Malekzadeh\u00a0R. Combined passive and active immunoprophylaxis for preventing perinatal transmission of the hepatitis B virus in infants born to HBsAg positive mothers in comparison with vaccine alone. Hepatol Res. 2006;36(4):265\u201371. https:\/\/doi.org\/10.1016\/j.hepres.2006.08.001.","journal-title":"Hepatol Res"},{"issue":"2","key":"748_CR32","doi-asserted-by":"publisher","first-page":"93","DOI":"10.26719\/2011.17.2.93","volume":"17","author":"A Esteghamati","year":"2011","unstructured":"Esteghamati\u00a0A, Keshtkar\u00a0AA, Nadjafi\u00a0L, Gouya\u00a0MM, Salaramoli\u00a0M, Roshandel\u00a0G, et\u00a0al. Hepatitis B vaccination coverage among Iranian children aged 15\u201326\u00a0months in 2006. East Mediterr Health\u00a0J. 2011;17(2):93\u2013100.","journal-title":"East Mediterr Health J"},{"issue":"4","key":"748_CR33","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1111\/j.1542-4758.2008.00284.x","volume":"16","author":"SM Alavian","year":"2007","unstructured":"Alavian\u00a0SM, Fallahian\u00a0F, Lankarani\u00a0KB. The changing epidemiology of viral hepatitis B in Iran. J\u00a0Gastrointestin Liver Dis. 2007;16(4):403\u20136. https:\/\/doi.org\/10.1111\/j.1542-4758.2008.00284.x.","journal-title":"J Gastrointestin Liver Dis"},{"issue":"4","key":"748_CR34","first-page":"281","volume":"8","author":"SM Alavian","year":"2008","unstructured":"Alavian\u00a0SM, Hajariazdeh\u00a0B, Ahmadzad Asl\u00a0M, Kabir\u00a0A, Bagheri Lankarani\u00a0KB. Hepatitis B virus infection in Iran: a systematic review. Hepat Mon. 2008;8(4):281\u201394.","journal-title":"Hepat Mon"},{"key":"748_CR35","doi-asserted-by":"publisher","DOI":"10.21037\/aob.2017.04.02","author":"T Li","year":"2017","unstructured":"Li\u00a0T, Fu\u00a0Y, Allain\u00a0J\u2011P, Li\u00a0C. Chronic and occult hepatitis B virus infections in the vaccinated Chinese population. Ann Blood. 2017; https:\/\/doi.org\/10.21037\/aob.2017.04.02.","journal-title":"Ann Blood"},{"key":"748_CR36","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1093\/infdis\/169.6.1374","volume":"169","author":"M Fortuin","year":"1994","unstructured":"Fortuin\u00a0M, Karthigesu\u00a0V, Allison\u00a0L, Howard\u00a0C, Hoare\u00a0S, et\u00a0al. Breakthrough infections and identification of a\u00a0viral variant in Gambian children immunized with hepatitis B vaccine. J\u00a0Infect Dis. 1994;169:1374\u20136.","journal-title":"J Infect Dis"},{"key":"748_CR37","doi-asserted-by":"publisher","first-page":"30","DOI":"10.7326\/M15-1121","volume":"164","author":"S Paul","year":"2016","unstructured":"Paul\u00a0S, Saxena\u00a0A, Terrin\u00a0N, Viveiros\u00a0K, Balk\u00a0EM, Wong\u00a0JB. Hepatitis B virus reactivation and prophylaxis during solid tumor chemotherapy: a\u00a0systematic review and meta-analysis. Ann Intern Med. 2016;164:30\u201340.","journal-title":"Ann Intern Med"},{"issue":"9","key":"748_CR38","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1111\/ped.13352","volume":"59","author":"K Yokoyama","year":"2017","unstructured":"Yokoyama\u00a0K, Kumagai\u00a0H, Takahashi\u00a0M, Nagashima\u00a0S, Okamoto\u00a0H, Yamagata\u00a0T. Occult hepatitis B virus infection in immunized children born to carrier mothers. Pediatr Int. 2017;59(9):1010\u20136.","journal-title":"Pediatr Int"},{"key":"748_CR39","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jcv.2014.11.032","volume":"63","author":"E Amponsah-Dacosta","year":"2015","unstructured":"Amponsah-Dacosta\u00a0E, Lebelo\u00a0RL, Rakgole\u00a0JN, Selabe\u00a0SG, Gededzha\u00a0MP, et al. Hepatitis B virus infection in postvaccination South Africa: occult HBV infection and circulating surface gene variants. J\u00a0Clin Virol. 2015;63:12\u20137. https:\/\/doi.org\/10.1016\/j.jcv.2014.11.032.","journal-title":"J Clin Virol"},{"issue":"2","key":"748_CR40","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.jhep.2008.09.017","volume":"50","author":"SC Mu","year":"2009","unstructured":"Mu\u00a0SC, Lin\u00a0YM, Jow\u00a0GM, Chen\u00a0BF. Occult hepatitis B virus infection in hepatitis B vaccinated children in Taiwan. J\u00a0Hepatol. 2009;50(2):264\u201372. https:\/\/doi.org\/10.1016\/j.jhep.2008.09.017.","journal-title":"J Hepatol"},{"issue":"10","key":"748_CR41","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1136\/gut.2003.034223","volume":"53","author":"HY Hsu","year":"2004","unstructured":"Hsu\u00a0HY, Chang\u00a0MH, Ni\u00a0YH, Chen\u00a0HL. Survey of hepatitis B surface variant infection in children 15 years after a\u00a0nationwide vaccination program in Taiwan. Gut. 2004;53(10):1499\u2013503. https:\/\/doi.org\/10.1136\/gut.2003.034223.","journal-title":"Gut"},{"issue":"5","key":"748_CR42","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1002\/hep.510300511","volume":"30","author":"HY Hsu","year":"1999","unstructured":"Hsu\u00a0HY, Chang\u00a0MH, Liaw\u00a0SH, Ni\u00a0YH, Chen HL.\u00a0Changes of hepatitis B surface antigen variants in carrier children before and after universal vaccination in Taiwan. Hepatology. 1999;30(5):1312\u20137. https:\/\/doi.org\/10.1002\/hep.510300511.","journal-title":"Hepatology"},{"issue":"4","key":"748_CR43","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.jhep.2012.05.021","volume":"57","author":"YH Ni","year":"2012","unstructured":"Ni\u00a0YH, Chang\u00a0MH, Wu\u00a0JF, Hsu\u00a0HY, Chen\u00a0HL, Chen\u00a0DS. Minimization of hepatitis B infection by a 25-year universal vaccination program. J\u00a0Hepatol. 2012;57(4):730\u20135. https:\/\/doi.org\/10.1016\/j.jhep.2012.05.021.","journal-title":"J Hepatol"},{"issue":"2","key":"748_CR44","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/jmv.24045","volume":"87","author":"E Darmawan","year":"2015","unstructured":"Darmawan\u00a0E, Turyadi, El-Khobar\u00a0KE, Nursanty\u00a0NK, Thedja\u00a0MD, Muljono\u00a0DH. Seroepidemiology and occult hepatitis B virus infection in young adults in Banjarmasin, Indonesia. J\u00a0Med Virol. 2015;87(2):199\u2013207. https:\/\/doi.org\/10.1002\/jmv.24045.","journal-title":"J Med Virol"},{"issue":"8","key":"748_CR45","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.4161\/hv.29521","volume":"10","author":"H Elrashidy","year":"2014","unstructured":"Elrashidy\u00a0H, El-Didamony\u00a0G, Elbahrawy\u00a0A, Hashim\u00a0A, Alashker\u00a0A, et al. Absence of occult hepatitis B virus infection in sera of diabetic children and adolescents following hepatitis B vaccination. Hum Vaccin Immunother. 2014;10(8):2336\u201341. https:\/\/doi.org\/10.4161\/hv.29521.","journal-title":"Hum Vaccin Immunother"},{"issue":"2","key":"748_CR46","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1053\/j.gastro.2012.05.002","volume":"143","author":"MW Lai","year":"2012","unstructured":"Lai\u00a0MW, Lin\u00a0TY, Tsao\u00a0KC, Huang\u00a0CG, Hsiao\u00a0MJ, et\u00a0al. Increased seroprevalence of HBV DNA with mutations in the S gene among individuals greater than 18 years old after complete vaccination. Gastroenterology. 2012;143(2):400\u20137. https:\/\/doi.org\/10.1053\/j.gastro.2012.05.002.","journal-title":"Gastroenterology"},{"issue":"12","key":"748_CR47","doi-asserted-by":"publisher","first-page":"3405","DOI":"10.1007\/s00705-016-3050-1","volume":"161","author":"MR Aghasadeghi","year":"2016","unstructured":"Aghasadeghi\u00a0MR, Velayati\u00a0AA, Mamishi\u00a0S, Nabavi\u00a0M, Aghakhani\u00a0A, et\u00a0al. Low prevalence of hepatitis B vaccine escape mutants among individuals born after the initiation of a\u00a0nationwide vaccination program in Iran. Arch Virol. 2016;161(12):3405\u201311. https:\/\/doi.org\/10.1007\/s00705-016-3050-1.","journal-title":"Arch Virol"}],"container-title":["Wiener Medizinische Wochenschrift"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10354-020-00748-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10354-020-00748-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10354-020-00748-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,8]],"date-time":"2021-04-08T23:47:02Z","timestamp":1617925622000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10354-020-00748-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,9]]},"references-count":47,"journal-issue":{"issue":"9-10","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["748"],"URL":"https:\/\/doi.org\/10.1007\/s10354-020-00748-z","relation":{},"ISSN":["0043-5341","1563-258X"],"issn-type":[{"value":"0043-5341","type":"print"},{"value":"1563-258X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,9]]},"assertion":[{"value":"28 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.R.\u00a0Aghasadeghi, A.\u00a0Aghakhani, S.\u00a0Mamishi, F.\u00a0Bidari-Zerehpoosh, M.-T.H.\u00a0Ashtiani, S.\u00a0Sabeti, M.\u00a0Banifazl, A.\u00a0Karami, A.\u00a0Bavand, and A.\u00a0Ramezani declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}